Tocilizumab (TCZ) may be an effective treatment for poly-juvenile idiopathic arthritis (pJIA) as for rheumatoid arthritis (RA) - Yamaguchi Ken-ichi; Kishimoto Mitsumasa; Okada Masato (BMC, 2012)